ADJUVANT TREATMENT OF GASTRIC-CANCER

被引:16
|
作者
MACDONALD, JS
SCHNALL, SF
机构
[1] Department of Medicine, Temple University Cancer Center, Philadelphia, 19140, Pennsylvania
关键词
D O I
10.1007/BF00308630
中图分类号
R61 [外科手术学];
学科分类号
摘要
Adenocarcinoma of the stomach represents a significant problem worldwide. The only known curative treatment of gastric cancer is complete surgical resection of the stomach tumor with surrounding lymph node-bearing areas. However, as many as 50% to 90% of patients undergoing gastric tumor resection relapse and die of cancer. Adjuvant chemotherapy has been used to prevent recurrence of gastric cancer after surgical resection. Single agents including thiotepa and fluorodeoxyuridine have no benefit as adjuvant therapy. Likewise, combination chemotherapy including 5-fluorouracil (5-FU) plus methyl-CCNU, 5-FU plus Adriamycin plus mitomycin C (FAM), and mitomycin C plus 5-FU plus cytosine arabinoside do not result in overall improved survival. Combined modality irradiation plus fluorinated pyrimidine, however, has resulted in long-term survival of patients with known residual gastric cancer. The newest clinical trial in postoperative gastric cancer being performed in the United States will test 5-FU plus leucovorin plus irradiation in a prospectively randomized study in patients with resected stage IB through stage TV stomach cancer. This surgical study, designed with excellent prospective quality control, is actively accruing patients and will be completed in 1.5 to 2.0 years.
引用
收藏
页码:221 / 225
页数:5
相关论文
共 50 条
  • [1] ADJUVANT TREATMENT IN GASTRIC-CANCER
    BEDENNE, L
    [J]. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1994, 18 (8-9): : 733 - 736
  • [2] ADJUVANT TREATMENT IN GASTRIC-CANCER
    AGBOOLA, O
    [J]. CANCER TREATMENT REVIEWS, 1994, 20 (03) : 217 - 240
  • [3] ADJUVANT TREATMENT FOR GASTRIC-CANCER
    LISE, M
    NITTI, D
    MARCHET, A
    FORNASIERO, A
    [J]. ANTI-CANCER DRUGS, 1991, 2 (05) : 433 - 445
  • [4] SURGICAL AND ADJUVANT TREATMENT FOR GASTRIC-CANCER
    CRAVEN, JL
    [J]. BRITISH JOURNAL OF CANCER, 1986, 54 (01) : 140 - 141
  • [5] ADJUVANT CHEMOTHERAPY IN GASTRIC-CANCER
    SCHLAG, P
    [J]. WORLD JOURNAL OF SURGERY, 1987, 11 (04) : 473 - 477
  • [6] INTRAPERITONEAL CISPLATIN - A NEW APPROACH TO THE ADJUVANT TREATMENT OF GASTRIC-CANCER
    CUNNINGHAM, D
    SAUVEN, P
    PARKER, M
    GLAZER, G
    COLEMAN, D
    COULTER, C
    CUNNINGHAM, D
    LENNOX, M
    HERMONTAYLOR, J
    COOMBES, RC
    KIRKHAM, JS
    ROSIN, RD
    [J]. BRITISH JOURNAL OF CANCER, 1989, 60 (03) : 458 - 458
  • [7] ADJUVANT THERAPY IN RESECTABLE GASTRIC-CANCER
    BLEIBERG, H
    GERARD, B
    DEGUIRAL, P
    [J]. BRITISH JOURNAL OF CANCER, 1992, 66 (06) : 987 - 991
  • [8] ADJUVANT AND CURATIVE CHEMOTHERAPY OF THE GASTRIC-CANCER
    ANDRYSEK, O
    LINHART, O
    JIRKOVSKY, J
    [J]. NEOPLASMA, 1985, 32 (04) : 499 - 506
  • [9] REVIEW OF ADJUVANT CHEMOTHERAPY FOR GASTRIC-CANCER
    NAKAJIMA, T
    [J]. WORLD JOURNAL OF SURGERY, 1995, 19 (04) : 570 - 574
  • [10] PERIOPERATIVE AND ADJUVANT CHEMOTHERAPY IN GASTRIC-CANCER
    SCHLAG, P
    SCHREML, W
    [J]. RECENT RESULTS IN CANCER RESEARCH, 1985, 98 : 116 - 121